# Eton Pharmaceuticals, Inc.: Form 8-K/A, filed Nov 18, 2025

- Company: [Eton Pharmaceuticals, Inc.](/companies/eton.md) (CIK 1710340)
- Form: 8-K/A
- Filed: 2025-11-18
- Accepted by EDGAR: Nov 18, 2025, 16:16 ET
- Period: 2024-12-19
- Accession: 0001437749-25-035597
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1710340/000143774925035597/eton20250314_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1710340/000143774925035597/

## Items reported

- Item 2.01: Completion of an acquisition or disposition
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1710340/000143774925035597/eton20250314_8ka.htm

Filed Nov 18, 2025.
Source: SEC EDGAR, the filing index for accession 0001437749-25-035597. Last ingested by Listed: Nov 6, 2026, 16:36 ET. No prices; not investment advice.